9月IPO受理，这些变化→

Core Viewpoint - The article discusses the recent IPO activities in the Chinese stock market, highlighting the trends in the semiconductor and biotechnology sectors, as well as the regulatory environment supporting innovation and new technologies [3][4][5][6][7]. IPO Activities - In September, a total of 10 IPOs were accepted across various exchanges, including 2 on the ChiNext, 2 on the Sci-Tech Innovation Board, 1 on the Shanghai Main Board, and 5 on the Beijing Stock Exchange [3]. - The total amount to be raised from these IPOs is approximately 179.53 billion yuan, with the largest being China Electric Power Construction New Energy Group, aiming to raise 9 billion yuan [6][7]. Semiconductor Sector - Two semiconductor companies, LaiPu Technology and Yueya Semiconductor, have been accepted for IPOs. LaiPu Technology focuses on advanced laser processing equipment for semiconductor manufacturing, with a planned fundraising of 850 million yuan [4][5]. - Yueya Semiconductor specializes in advanced packaging materials and plans to raise 1.224 billion yuan for expansion projects related to AI [5]. Biotechnology Sector - An innovative biopharmaceutical company, Anshi Biotechnology, is pursuing an IPO on the Sci-Tech Innovation Board, aiming to raise 2.45 billion yuan for new drug development and operational funding [6]. - Anshi Biotechnology focuses on oncology and has several drugs in various stages of development, including one that has already been commercialized [6]. Regulatory Environment - The regulatory authorities have introduced policies to support technological innovation and the development of new production capabilities, including the reactivation of the fifth set of listing standards for the Sci-Tech Innovation Board [6].